Evidence map›Paper›PMID 41768142›Full record

ArticleFrontiers in transplantation2026

Impaired graft survival in kidney transplants from expanded criteria donors with HLA-DR mismatch.

Uwe Scheuermann, Philipp Rhode, Claudia Lehmann, Jan Kowald, Sophie Seiffer, Fabian Haak, Daniel Seehofer, Sebastian Murad Rabe, Hans-Michael Tautenhahn

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in transplantation, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Uwe ScheuermannDepartment of Visceral, Transplantation, Vascular and Thoracic Surgery, University Hospital of Leipzig, Leipzig, Germany.
Philipp RhodeDepartment of Visceral, Transplantation, Vascular and Thoracic Surgery, University Hospital of Leipzig, Leipzig, Germany.
Claudia LehmannHLA Laboratory, Institute for Transfusion Medicine, University Hospital Hamburg-Eppendorf, Hamburg, Germany.
Jan KowaldMedical Department III, Division of Nephrology, University of Leipzig Medical Center, Leipzig, Germany.
Sophie SeifferDepartment of Visceral, Transplantation, Vascular and Thoracic Surgery, University Hospital of Leipzig, Leipzig, Germany.
Fabian HaakDepartment of Visceral, Transplantation, Vascular and Thoracic Surgery, University Hospital of Leipzig, Leipzig, Germany.
Daniel SeehoferDepartment of Visceral, Transplantation, Vascular and Thoracic Surgery, University Hospital of Leipzig, Leipzig, Germany.
Sebastian Murad Rabe *Department of Visceral, Transplantation, Vascular and Thoracic Surgery, University Hospital of Leipzig, Leipzig, Germany.
Hans-Michael Tautenhahn *Department of Visceral, Transplantation, Vascular and Thoracic Surgery, University Hospital of Leipzig, Leipzig, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Human leukocyte antigen (HLA)-DR mismatches are known to increase the risk of graft rejection following kidney transplantation (KT). Especially in KT using grafts of lower quality from expanded criteria donors (ECD), the immune response plays a critical role. Therefore, the aim of this study was to investigate the impact of HLA-DR mismatches on both short- and long-term outcomes in primary ECD KT. 537 KT recipients were stratified into four groups based on their HLA-DR mismatch status [absent (-) or present (+)] and donor type [standard criteria donor (SCD) or ECD]: (1) SCD-DR-(

Indexed as

expanded criteria donorHLA-DRkidney transplantationmismatchoutcomesurvival

Identifiers

PMID41768142
PMCPMC12936035

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.